Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors.
Rodriguez BL, Huang J, Gibson L, Fradette JJ, Chen HH, Koyano K, Cortez C, Li B, Ho C, Ashique AM, Lin VY, Crawley S, Roda JM, Chen P, Fan B, Kim J, Sissons J, Sitrin J, Kaplan DD, Gibbons DL, Rivera LB.
Rodriguez BL, et al.
Mol Cancer Ther. 2024 Apr 22. doi: 10.1158/1535-7163.MCT-23-0866. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38648067